Neurological disorders associated with anti-AP3B2 antibodies may manifest as cerebellar ataxia, myeloneuropathy, sensory ataxia, dysautonomia, and overlapping manifestations of these conditions (4). This evidence concerns the gene AP3B2 and aceruloplasminemia.